Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-01 Sarchi Christopher Chief Commercial Officer Sale 10b5-1 −12,000 $9.24 $111K 180,962
2026-05-18 Sarchi Christopher Chief Commercial Officer Sale −8,626 $5.08 $44K 192,962
2026-04-02 Sarchi Christopher Chief Commercial Officer Sale 10b5-1 −6,500 $8.01 $52K 151,588
2026-04-01 Sarchi Christopher Chief Commercial Officer Grant or award +50,000 201,588
2026-04-01 Sarchi Christopher Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2025-12-19 Sarchi Christopher Chief Commercial Officer Grant or award +35,000 158,088
2025-11-17 Sarchi Christopher Chief Commercial Officer Sale −5,208 $9.10 $47K 123,088
2025-05-20 Sarchi Christopher Chief Commercial Officer Sale −3,749 $8.05 $30K 128,296
2025-04-01 Sarchi Christopher Chief Commercial Officer Grant or award +45,000 132,045
2025-04-01 Sarchi Christopher Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +67,500 67,500
2024-11-18 Sarchi Christopher Chief Commercial Officer Sale −5,207 $10.78 $56K 87,045
2024-05-16 Sarchi Christopher Chief Commercial Officer Sale −2,218 $6.47 $14K 92,252
2024-04-01 Sarchi Christopher Chief Commercial Officer Grant or award +22,225 94,470
2024-04-01 Sarchi Christopher Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +66,675 66,675
2023-11-16 Sarchi Christopher Chief Commercial Officer Sale −5,255 $10.92 $57K 72,245

Page 1 of 1 · 15 trades